Vaccine Preventable Diseases

Reproductive and Child Health

Conditions Associated with Poverty

Libraries and Public Access to Information

Education

Pacific Northwest

Special Projects

VACCINE PREVENTABLE DISEASES

Vaccines are the foundation of infectious disease control and represent the best hope for improving the health and well-being of the world's poorest children. Foundation priorities include expanding access to life-saving vaccines for the world's poorest children and developing new vaccines against diseases such as HIV/AIDS, tuberculosis, and malaria.

The Children's Vaccine Program in New Delhi, India, goes out to the slum that runs the periphery of the city to immunize children under five from polio. A high percentage of these babies are malnourished and underweight.

Albert B. Sabin Vaccine Institute, Inc., The (New Canaan, CT)
$500,000 for 5 years to support the annual Vaccine Colloquia.

Albert B. Sabin Vaccine Institute, Inc., The (New Canaan, CT)
$18,000,000 for 6 years to develop a genetically engineered recombinant hookworm vaccine to be used with traditional methods to reduce one of the main causes of anemia and malnutrition.

Infectious Disease Research Institute (Seattle, WA)
$15,000,000 for 4 years to develop a vaccine for leishmaniasis.

Johns Hopkins University, The (Baltimore, MD)
$21,400,000 for 5 years to develop a stealth measles vaccine.

Management Sciences for Health, Inc. (Boston, MA)
$29,957,826 for 5 years to establish the Gates Drug Management Center to provide sustainable access to priority drugs, vaccines, and essential health commodities in underserved areas.

U.S. Civilian Research & Development Foundation For Independent State Of The Former Soviet Union (Arlington, VA)
$170,092 for 8 months to perform a feasibility study to improve vaccine manufacturing and delivery in Russia.

United States Fund for UNICEF (New York, NY)
$300,000 for 1 year to support the GAVI Secretariat.

University of Maryland (College Park, MD)
$20,360,592 for 5 years to develop a stealth measles vaccine.

University of Southern California (Los Angeles, CA)
$40,000 for 1 year to support the Vaccine Leadership Conference.